Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline.

  title={Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline.},
  author={Davendra P. S. Sohal and Pamela B. Mangu and Alok A. Khorana and Manish Shah and Philip Agop Philip and Eileen M. O'Reilly and Hope Elizabeth Uronis and Ramesh K. Ramanathan and Christopher H. Crane and Anitra Engebretson and Joseph T. Ruggiero and Mehmet Sitki Copur and Michelle Wan Yee Lau and Susan C Urba and Daniel A. Laheru},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  volume={34 23},
PURPOSE To provide evidence-based recommendations to oncologists and others for the treatment of patients with metastatic pancreatic cancer. METHODS American Society of Clinical Oncology convened an Expert Panel of medical oncology, radiation oncology, surgical oncology, gastroenterology, palliative care, and advocacy experts to conduct a systematic review of the literature from April 2004 to June 2015. Outcomes were overall survival, disease-free survival, progression-free survival, and… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 20 times over the past 90 days. VIEW TWEETS
35 Citations
64 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 35 extracted citations


Publications referenced by this paper.
Showing 1-10 of 64 references

Costeffectiveness of nab-paclitaxel plus gemcitabine versus erlotinib plus gemcitabine in metastatic pancreatic cancer

  • EG Chiorean, S Whiting, G Binder
  • J Clin Oncol
  • 2014
1 Excerpt

Makharita MY: Neurolytic sympathectomy in the management of cancer pain-time effect: A prospective, randomized multicenter study

  • YM Amr
  • J Pain Symptom Manage 48:944-956,
  • 2014
1 Excerpt

Similar Papers

Loading similar papers…